# Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals

> **NCT04858607** · — · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 373 (actual)

## Conditions studied

- Covid19
- Immunosuppression

## Interventions

- **DIAGNOSTIC_TEST:** Blood sample
- **DIAGNOSTIC_TEST:** Saliva sample

## Key facts

- **NCT ID:** NCT04858607
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-19
- **Primary completion:** 2023-01-20
- **Final completion:** 2023-01-20
- **Target enrollment:** 373 (ACTUAL)
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04858607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04858607, "Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04858607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*